Enterprise AI Adoption at a Moment of Maximum Skepticism - with Nishtha Jain of Takeda Pharmaceuticals

Today's guest is Nishtha Jain, AI Innovation and Strategy Leader in the Biopharma Industry at Takeda Pharmaceuticals. Nishtha leads enterprise data and AI strategy in the biopharma sector, focusing on aligning advanced analytics and AI systems with real-world clinical, regulatory, and operational workflows.

Nishtha joins Emerj Client Narrative & Content Strategy Lead Nick Gertsch to examine why most enterprise AI pilots fail to scale, how unrealistic expectations and poorly defined use cases undermine ROI, and what it takes to design human-centered AI systems that fit how teams actually work in regulated environments. Nishtha also breaks down practical frameworks for measuring value beyond headcount reduction, including return on employee experience and long-term capability building, along with concrete approaches to faster experimentation, customer-driven use-case prioritization, and building flexible operating models that adapt as technology and market conditions evolve.

Want to share your AI adoption story with executive peers? Click emerj.com/expert2 for more information and to be a potential future guest on the 'AI in Business' podcast! If you've enjoyed or benefited from some of the insights of this episode, consider leaving us a five-star review on Apple Podcasts, and let us know what you learned, found helpful, or liked most about this show!